A trial looking at lapatinib and trastuzumab for breast cancer that has not spread (ALTTO)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 3

Details

This trial was looking at lapatinib and trastuzumab (Herceptin) to see which was best at stopping breast cancer from coming back after treatment. It was for people with breast cancer that produces too much of a protein called . This is known as HER2 positive breast cancer.

Recruitment start: 25 October 2007

Recruitment end: 30 June 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Ian Smith

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

GlaxoSmithKline (GSK)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUKE/07/045.

Last reviewed: 16 April 2015

CRUK internal database number: 1010

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.